We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
-14.94%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$5.89B
AUM Growth
-$1.19B
Cap. Flow
+$12.1M
Cap. Flow %
0.21%
Top 10 Hldgs %
20.78%
Holding
233
New
6
Increased
73
Reduced
123
Closed
13

Top Buys

Rank Stock Value
1
SCS
Steelcase
SCS
+$38.6M
2
GE icon
GE Aerospace
GE
+$9.7M
3
BUD icon
AB InBev
BUD
+$8.07M
4
CHTR icon
Charter Communications
CHTR
+$7.72M
5
CMCSA icon
Comcast
CMCSA
+$6.57M

Sector Composition

Rank Sector Weight
1 Financials 19.46%
2 Technology 15.91%
3 Healthcare 15.73%
4 Communication Services 8.16%
5 Industrials 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQIX icon
26
Equinix
EQIX
$104B
$74.8M 1.27%
113,794
-4,149
-4% -$2.87M
CVX icon
27
Chevron
CVX
$371B
$73.4M 1.25%
507,065
-8,068
-2% -$1.33M
ORCL icon
28
Oracle
ORCL
$413B
$70.2M 1.19%
1,004,854
-11,390
-1% -$834K
EOG icon
29
EOG Resources
EOG
$71.4B
$68.8M 1.17%
623,389
-63,884
-9% -$7.93M
USB icon
30
US Bancorp
USB
$99.4B
$68.6M 1.17%
1,491,467
-23,480
-2% -$1.17M
DAL icon
31
Delta Air Lines
DAL
$60.5B
$68.3M 1.16%
2,358,570
+30,098
+1% +$1.15M
CVS icon
32
CVS Health
CVS
$123B
$68.1M 1.16%
735,148
+7,022
+1% +$685K
SHEL icon
33
Shell
SHEL
$248B
$67.6M 1.15%
1,293,549
-26,649
-2% -$1.5M
AES icon
34
AES
AES
$10.5B
$67.2M 1.14%
3,198,149
+9,651
+0.3% +$211K
ZBH icon
35
Zimmer Biomet
ZBH
$18.8B
$67.1M 1.14%
639,050
+29,366
+5% +$3.48M
IFF icon
36
International Flavors & Fragrances
IFF
$21.6B
$63.9M 1.09%
536,685
+20,974
+4% +$2.62M
JNJ icon
37
Johnson & Johnson
JNJ
$619B
$63.3M 1.08%
356,851
+7,638
+2% +$1.36M
CHTR icon
38
Charter Communications
CHTR
$18.8B
$62.2M 1.06%
132,779
+15,832
+14% +$7.72M
ILMN icon
39
Illumina
ILMN
$29.3B
$59M 1%
329,208
+5,221
+2% +$1.33M
HON icon
40
Honeywell
HON
$76.3B
$55.8M 0.95%
340,328
+927
+0.3% +$166K
DIS icon
41
Walt Disney
DIS
$182B
$54.2M 0.92%
574,410
+38,462
+7% +$4.27M
TFC icon
42
Truist Financial
TFC
$64.2B
$53.5M 0.91%
1,127,064
+3,575
+0.3% +$176K
MRK icon
43
Merck
MRK
$317B
$52.3M 0.89%
573,268
-6,227
-1% -$552K
CMCSA icon
44
Comcast
CMCSA
$89.3B
$52.1M 0.89%
1,328,719
+153,178
+13% +$6.57M
ELAN icon
45
Elanco Animal Health
ELAN
$12.1B
$50.1M 0.85%
2,553,485
+57,964
+2% +$1.37M
TDG icon
46
TransDigm Group
TDG
$69.8B
$48.7M 0.83%
90,772
+4,676
+5% +$2.76M
IBM icon
47
IBM
IBM
$220B
$48.3M 0.82%
342,019
+1,700
+0.5% +$229K
GE icon
48
GE Aerospace
GE
$389B
$47.5M 0.81%
1,196,619
+200,179
+20% +$9.7M
MAXR
49
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$47.4M 0.8%
1,815,835
-16,336
-0.9% -$508K
META icon
50
Meta Platforms (Facebook)
META
$1.5T
$47.3M 0.8%
293,438
+5,138
+2% +$991K

Similar funds

Douglas Lane & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Douglas Lane & Associates held 233 positions worth $5.89B, down 17% from $7.08B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Douglas Lane & Associates's Q2 2022 filing shows 6 new, 73 increased, 123 reduced and 13 closed positions. Its largest new stake was Warner Bros: 229,098 shares worth $3.07M. The largest sale was APA Corp, an estimated $12.5M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • Douglas Lane & Associates's largest Q2 2022 buy was Warner Bros: 229,098 shares worth $3.07M.
  • Douglas Lane & Associates added most to Steelcase in Q2 2022, an estimated $38.6M increase.
  • Douglas Lane & Associates's biggest Q2 2022 reduction was APA Corp, cutting an estimated $12.5M.
  • Douglas Lane & Associates fully exited Cerner Corp in Q2 2022, selling an estimated $4.06M.
  • Douglas Lane & Associates's ten largest holdings make up 21% of its $5.89B portfolio in Q2 2022.
  • Douglas Lane & Associates opened 6 new positions and closed 13 in Q2 2022.
  • Douglas Lane & Associates's portfolio value fell 17% quarter-over-quarter to $5.89B.

Based on Douglas Lane & Associates's 13F filing for Q2 2022, filed 18 Jul 2022.